Prospective Study of Sequential Reduction in Immunosuppression, Interferon Alpha-2B, and Chemotherapy for Posttransplantation Lymphoproliferative Disorder

BACKGROUND: Several interventions can cure posttransplant lymphoproliferative disease (PTLD); a sequential approach is usual, starting with reduction in immunosuppressives (RI). The efficacy of RI remains poorly defined, particularly in adults. We assessed an algorithm starting with a defined course...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Swinnen, Lode J., LeBlanc, Michael, Grogan, Thomas M., Gordon, Leo I., Stiff, Patrick J., Miller, Alan M., Kasamon, Yvette, Miller, Thomas P., Fisher, Richard I.
Format: Artigo
Idioma:Inglês
Publicat: 2008
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4029101/
https://ncbi.nlm.nih.gov/pubmed/18645482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TP.0b013e3181761659
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars